These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2129261)

  • 1. Endogenous hyperinsulinemia and release of growth hormone following a glucose load as well as in response to thyrotropin releasing hormone in acromegaly.
    Saad MJ; Moreira AC; Foss MC
    Braz J Med Biol Res; 1990; 23(10):953-7. PubMed ID: 2129261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired glucose tolerance coincides with abnormal release of growth hormone following a glucose load as well as in response to TRH in acromegaly.
    Zárate A; García IC; Morán C; Fonseca ME
    Horm Metab Res; 1986 Jun; 18(6):400-1. PubMed ID: 3089892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do "so-called" normal growth hormone concentrations (2-5 micrograms/l) indicate cure in acromegaly?
    Levitt NS; Ratanjee BD; Abrahamson MJ
    Horm Metab Res; 1995 Apr; 27(4):185-8. PubMed ID: 7750902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The control on growth hormone release by free fatty acids is maintained in acromegaly.
    Lanzi R; Losa M; Mignogna G; Caumo A; Pontiroli AE
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1234-8. PubMed ID: 10199760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
    Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
    J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.
    Watanobe H; Sasaki S; Sone K; Takebe K
    J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of treated acromegalic patients with normal growth hormone levels during oral glucose load.
    Rieu M; Kuhn JM; Bricaire H; Luton JP
    Acta Endocrinol (Copenh); 1984 Sep; 107(1):1-8. PubMed ID: 6435366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
    Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G
    Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
    Hanew K; Aida M; Sasaki A; Mouri T; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):53-62. PubMed ID: 104407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical responsiveness of growth hormone to corticotropin-releasing factor in acromegaly.
    Pieters GF; Hermus AR; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1984 Mar; 58(3):560-2. PubMed ID: 6420444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory action of oral thyrotropin-releasing hormone on the glucoregulatory response of the oral glucose tolerance test.
    Duntas LH; Papanastasiou L; Mantzou E; Jehle P; Mantzos I; Koutras DA
    Thyroid; 1998 Oct; 8(10):929-33. PubMed ID: 9827661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K; Aida M; Tano T; Yoshinaga K
    Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F; Müller EE
    J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.